BirchBioMed Inc. announces Hamilton Health Sciences’ Centre for Burn Research in Ontario as first clinical trial site for pioneering burns scar treatment
Guelph (August 28, 2025) – BirchBioMed Inc., a leading biopharmaceutical company and expert in the development of products for scarring and other fibrosis-related disorders, is thrilled to announce Hamilton Health Sciences’ (HHS) Centre for Burn Research in Ontario, Canada, as the first contracted clinical trial site for its Phase II/III randomized study of the naturally-based […]